Dysfunctional immune-privilege in morbid obesity: Implications and effect of gastric bypass surgery

被引:29
|
作者
Cottam, DR [1 ]
Schaefer, PA [1 ]
Shaftan, GW [1 ]
Angus, LDG [1 ]
机构
[1] Nassau Univ, Med Ctr, Dept Surg, E Meadow, NY USA
关键词
morbid obesity; cancer; apoptosis; chronic; inflammation; L-selectin; Fas antigen; CD62L; CD95; lymphocyte; neutrophil; flow cytometry; immune privilege; bariatric surgery; gastric bypass;
D O I
10.1381/096089203321136584
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Despite the epidemiological evidence linking obesity and cancer, there has never been a causal link. We believe the chronic inflammation present,in obesity may predispose the obese to cancer through Fas-receptor over-expression and L-selectin under-expression in leukocytes, and elevated Fas ligand secretion in tumors affecting the morbidly obese. Methods: Leukocytes from 25 patients having gastric,;bypass surgery were compared to 15 normal controls preoperatively and at 1, 3,6, and 12 months post-operatively using flow cytometry to measure CD3, CD4, CD8, CD56, CD62 (L-selectin), CD 69, and CD95 (Fas antigen) expression on T lymphocytes, B lymphocytes, natural killer cells, and neutrophils. Results: The percentage of CD95+T cells was significantly elevated from controls (69.4% vs 56%, P=0.005). This difference persisted through 1 month postoperatively. Furthermore, expression of CD95 per cell, was significantly greater in these patients than that of the controls (80.2 vs 62.6 gmf, P=0.018) preoperatively, and this continued to 1 month. Polymorphonuclear cells also displayed a similar elevation in CD95 gmf expression preoperatively (54.1 vs 40.7 gmf, P=0.023) which normalized by 3 months. Natural killer cells did not display elevated numbers of CD95 gmf preoperatively, but they did experience a significant decline by 12 months. Additionally, there was significant reduction in the number of naive T cells [(T cells without L-selectin (CD62L)], when compared to normals preoperatively (41.8% vs 51.3%, P=0.001). There was no statistical difference between the postoperative patients and the controls by 3 months. CD69 was not different at baseline from controls in T or B cells, but there was a significant decrease by 12 months. Conclusion: The reduced expression of L-selectin combined with the elevated levels of CD95 suggests that morbid obesity predisposes patients to sites of immune privilege. This could be the mechanism for increased rates of cancer and wound infections seen in obesity. Surgically-induced weight loss eliminates these risk factors.
引用
收藏
页码:49 / 57
页数:9
相关论文
共 50 条
  • [41] Bowel obstruction after open and laparoscopic gastric bypass surgery for morbid obesity
    Capella, Rafael F.
    Iannace, Vincent A.
    Capella, Joseph F.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2006, 203 (03) : 328 - 335
  • [42] GASTRIC BYPASS OPERATION IN MORBID-OBESITY
    ANTAL, SC
    KOVACS, ZG
    [J]. ISRAEL JOURNAL OF MEDICAL SCIENCES, 1980, 16 (9-10): : 672 - 677
  • [43] Princeps procedure of gastric bypass for morbid obesity
    Lointier, P.
    [J]. ANNALES DE CHIRURGIE, 2006, 131 (6-7): : 405 - 408
  • [44] Pregnancy Following Gastric Bypass for Morbid Obesity
    Alan C Wittgrove
    Leslie Jester
    Perri Wittgrove
    G Wesley Clark
    [J]. Obesity Surgery, 1998, 8 : 461 - 464
  • [45] Pregnancy following gastric bypass surgery for morbid obesity: Maternal and neonatal outcomes
    Wax, Joseph R.
    Cartin, Angelina
    Wolff, Renee
    Lepich, Sharon
    Pinette, Michael G.
    Blackstone, Jacquelyn
    [J]. OBESITY SURGERY, 2008, 18 (05) : 540 - 544
  • [46] Crohn's disease after gastric bypass surgery for morbid obesity: Is there an association?
    Ahn, LB
    Huang, CS
    Forse, RA
    Hess, DT
    Andrews, C
    Farraye, FA
    [J]. INFLAMMATORY BOWEL DISEASES, 2005, 11 (06) : 624 - U21
  • [47] Eating Behavior and the Experience of Hunger Following Gastric Bypass Surgery for Morbid Obesity
    Catherine R Delin
    James McK Watts
    Judith L Saebel
    Paul G Anderson
    [J]. Obesity Surgery, 1997, 7 : 405 - 413
  • [48] Helicobacter pylori Infection in Patients Undergoing Gastric Bypass Surgery for Morbid Obesity
    Andrew A Renshaw
    Jorge R Rabaza
    Anthony M Gonzalez
    Juan-Carlos Verdeja
    [J]. Obesity Surgery, 2001, 11 : 281 - 283
  • [49] COMPLICATIONS OF GASTRIC BYPASS FOR MORBID-OBESITY
    BUCKWALTER, JA
    HERBST, CA
    [J]. AMERICAN JOURNAL OF SURGERY, 1980, 139 (01): : 55 - 60
  • [50] Morbid obesity, gastric bypass and metabolic syndrome
    Silvestre, V
    Ruano, M
    Castro, R
    García-Lescún, G
    Aguirregoicoa, E
    Rodríguez, A
    Marco, A
    García-Blanch, G
    [J]. OBESITY SURGERY, 2006, 16 (04) : 432 - 432